PFN2 and cancer: Moreover, in vitro assays revealed the biological role of PFN2 in facilitating the migration and invasion of cancer cells by regulating the EMT phenotype of ESCC, thereby proving that PFN2 might be a potential biomarker for the diagnosis and a therapeutic target for the treatment of ESCC.